Related Experiment Video
Updated: Oct 22, 2025
08:23
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
13.0K
Color-Coded Droplets and Microscopic Image Analysis for Multiplexed Antibiotic Susceptibility Testing
Yunjin Jeong1, Haewook Jang2, Junwon Kang2,3
1Bio-MAX Institute, Seoul National University, Seoul 08826, Korea.
Biosensors
|August 26, 2021
Summary
Antibiotic resistance is a global threat. This study introduces a color-coded droplet system for scalable antibiotic susceptibility testing (AST), improving drug discovery and clinical treatment strategies.
Area of Science:
- Microbiology
- Biotechnology
- Drug Discovery
Background:
- Antibiotic resistance poses a significant global health threat.
- Current antibiotic susceptibility testing (AST) methods lack scalability for comprehensive drug screening.
- Efficient AST is critical for selecting appropriate antibiotics in clinical settings.
Purpose of the Study:
- To develop a scalable and multiplexed antibiotic susceptibility testing (AST) platform.
- To overcome the limitations of traditional AST methods in terms of antibiotic and concentration diversity.
- To enable high-throughput screening for antimicrobial efficacy.
Main Methods:
- Utilized color-coded droplets to differentiate antibiotic type and concentration.
- Employed image processing analysis to detect droplets and measure bacterial growth.
- Tested the system with *E. coli* ATCC 25922 against ampicillin, gentamicin, and tetracycline.
Main Results:
- Demonstrated a robust and scalable platform for multiplexed AST.
- Successfully differentiated antibiotic type and concentration using color codes and density.
- Quantified bacterial growth inhibition within individual droplets via image analysis.
Conclusions:
- The color-coded droplet system offers a scalable solution for multiplexed antibiotic susceptibility testing.
- This innovative approach can be adapted for various drug testing systems requiring diverse conditions.
- The platform holds potential for accelerating antibiotic discovery and optimizing clinical treatment decisions.
